Author:
Mpwate Mireille Avilaw,Mbambu Eddy Mampuya,Lema Gabriel Mabuaka,Matanda Christian Nzanza,Mupepe Dominique Mayuku,Kaswa Michel Kayomo,Aloni Murielle Luengiladio,Anshambi Nicole Muzutie,Matuta Fabrice Mankangu,Lukasu Luc Losenga,Mpwate Serge Katya,Akilimali Pierre Zalagile,Kashongwe Innocent Murhula,Kashongwe Zacharie Munogolo,Kayembe Jean Marie Ntumba,Matanda Richard Nzanza
Publisher
Scientific Research Publishing, Inc.
Reference46 articles.
1. World Health Organization (2019) Global Tuberculosis Report 2019. Geneva. https://www.who.int/publications/i/item/9789241565714
2. Kashongwe, I., Anshambi, N, Maingowa, N, Aloni, M, Kaswa, M, Kayembe, J.M, et al. (2020) Use of Bedaquiline as Replacement for Aminoglycosides in the Shorter Regimen for Multidrug-Resistant Tuberculosis Patients with Hearing Loss: A Report of 39 Cases in Kinshasa, Democratic Republic of the Congo. Journal of Pulmonary & Respiratory Medicine, 10, 1-6.
3. Implementing a Short Regimen for Multidrug-Resistant Tuberculosis in Kinshasa, Democratic Republic of Congo: A Cohort Study 2014-2017
4. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries
5. World Health Organization (2020) WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment: Drug-Resistant Tuberculosis Treatment. https://iris.who.int/bitstream/handle/10665/332397/9789240007048